HuGE Literature Finder
Records
1
-
4
Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis. Annals of clinical and laboratory science 2016 Dec 46 (6): 586-591. Alexoudi Athanasia, Zachaki Sophia, Stavropoulou Chrysa, Gavrili Stavroula, Spiliopoulou Chara, Papadodima Stavroula, Karageorgiou Clementine E, Sambani Constanti |
Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis. The International journal of neuroscience 2015 Jan 125 (1): 32-7. Alexoudi Athanasia, Zachaki Sophia, Stavropoulou Chrysa, Chatzi Ioanna, Koumbi Daphne, Stavropoulou Kalliopi, Kollia Panagoula, Karageorgiou Clementine E, Sambani Constanti |
NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis. BMC neurology 2014 14 (1): 87. Agúndez José A G, García-Martín Elena, Martínez Carmen, Benito-León Julián, Millán-Pascual Jorge, Calleja Patricia, Díaz-Sánchez María, Pisa Diana, Turpín-Fenoll Laura, Alonso-Navarro Hortensia, Ayuso-Peralta Lucía, Torrecillas Dolores, Plaza-Nieto José Francisco, Jiménez-Jiménez Félix Javi |
The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease. Free radical biology & medicine 2011 Aug 51 (3): 713-8. Stavropoulou Chrysa, Zachaki Sophia, Alexoudi Athanasia, Chatzi Ioanna, Georgakakos Vasileios N, Terzoudi Georgia I, Pantelias Gabriel E, Karageorgiou Clementine E, Sambani Constanti |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 18, 2022
- Content source: